ChemoradiotherapyCombined Modality TherapyRadiotherapy DosageRadiotherapyRadiotherapy, AdjuvantAntibodies, Monoclonal, HumanizedCisplatinAntineoplastic Combined Chemotherapy ProtocolsFluorouracilRadiotherapy, ConformalChemotherapy, AdjuvantTreatment OutcomeHead and Neck NeoplasmsChemoradiotherapy, AdjuvantDose FractionationCarcinoma, Squamous CellDacarbazineNasopharyngeal NeoplasmsDisease-Free SurvivalRadiotherapy, Intensity-ModulatedNeoplasm StagingAntibodies, MonoclonalBrain NeoplasmsEsophageal NeoplasmsRadiation InjuriesSurvival RateOrganoplatinum CompoundsNeoadjuvant TherapyRadiotherapy, High-EnergyRadiotherapy Planning, Computer-AssistedLung NeoplasmsAntineoplastic AgentsSurvival Analysisras ProteinsMucositisNeoplasm Recurrence, LocalInduction ChemotherapyRetrospective StudiesColorectal NeoplasmsCarcinoma, Non-Small-Cell LungLaryngeal NeoplasmsBrachytherapyRectal NeoplasmsHypopharyngeal NeoplasmsKaplan-Meier EstimateCarboplatinDrug Administration ScheduleEsophagitisRadiation-Sensitizing AgentsTaxoidsPrognosisDeoxycytidineOropharyngeal NeoplasmsFollow-Up StudiesAdenocarcinomaRadiotherapy, Computer-AssistedRadiotherapy, Image-GuidedPaclitaxelUterine Cervical NeoplasmsDeglutition DisordersPharyngectomyOxonic AcidAntimetabolites, AntineoplasticFeasibility StudiesTegafurRadiation OncologyNeoplasms, Squamous CellEtoposideRemission InductionPositron-Emission TomographyReceptor, Epidermal Growth FactorDose-Response Relationship, RadiationTime FactorsEsophagectomyOrgan Sparing TreatmentsCarcinoma, Small CellLymphatic MetastasisRadiosurgeryTreatment FailureCamptothecinRadiation ToleranceRadiation PneumonitisPelvic NeoplasmsNeoplasm MetastasisLeucovorinRadiation DosageRandomized Controlled Trials as TopicTomography, X-Ray ComputedCranial IrradiationPreoperative CareCarcinomaOrgans at RiskRadiodermatitisVincristineSalvage TherapyNeoplasmsLymphatic IrradiationLaryngectomyParticle AcceleratorsPancreatic Neoplasms